ILUSTRASI. Pfizer Inc reported a 78% jump in profit and reaffirmed the combined 2022 sales forecast of US$ 54 billion for its Covid-19 vaccine and pill. REUTERS/Matthew Childs
Sumber: Reuters | Editor: Anastasia Lilin Yuliantina
KONTAN.CO.ID - Pfizer Inc on Thursday reported a 78% jump in profit and reaffirmed the combined 2022 sales forecast of US$ 54 billion for its Covid-19 vaccine and pill as demand for coronavirus products remains strong.
Shares rose 1% in premarket trading as overall net income rose to US$ 9,91 billion despite a stronger dollar.
Hanya Rp 5.000 untuk membaca artikel ini.
BELI SEKARANG
